Phase I Trial of Arsenic Trioxide in Combination With Pamidronate Disodium

Trial Profile

Phase I Trial of Arsenic Trioxide in Combination With Pamidronate Disodium

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Oct 2016

At a glance

  • Drugs Arsenic trioxide (Primary) ; Pamidronic acid
  • Indications Multiple myeloma; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top